The current discovery that the gut microbiome, which contains roughly 100 trillion microbes, affects health and disease has catalyzed a boom in multidisciplinary research efforts focused on understanding this relationship. Also, it is commonly demonstrated that the gut and the CNS are closely related in a bidirectional pathway. A balanced gut microbiome is essential for regular brain activities and emotional responses. On the other hand, the CNS regulates the majority of GI physiology. Any disruption in this bidirectional pathway led to a progression of health problems in both directions, neurological and gastrointestinal diseases. In this review, we hope to shed light on the complicated connections of the microbiome-gut-brain axis and the critical roles of gut microbiome in the early development of the brain in order to get a deeper knowledge of microbiome-mediated pathological conditions and management options through rebalancing of gut microbiome.
Obsessive-compulsive disorder (OCD) is a common condition that has a significant impact on people’s lives. COVID-19 pandemic imposed a challenging situation for the general population with new precautionary measures. All that can have serious implications for those who already have intense concerns about cleanliness and hygiene and those diagnosed with OCD. The aim of this study was to examine the impact of the coronavirus disease 2019 (COVID-19) pandemic on the emergence and severity of obsession and compulsion symptoms in Saudi Arabia. This was a cross-sectional study with 1,190 participants who completed an online three-part questionnaire that included sociodemographic data, the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) checklist, and (Y-BOCS) severity scale. On account of the fact that OCD requires a clinical evaluation to confirm the diagnosis, screening positive for OCD was defined based on criteria A of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), which is selecting at least one of either obsession or compulsion symptoms or both. Screening positive for obsession was defined as selecting at least one of the obsessional symptoms while screening positive for compulsion was defined as selecting at least one of the compulsion symptoms. Overall, OCD screening was positive in 82% of participants. Previous diagnosis of OCD was reported by 2.6% (N=36) of the participants and 55.2% of them reported that their symptoms did not change during the pandemic, while 41.1% reported that their symptoms increased. Positive OCD screening was significantly higher in participants who reported previous psychological illness (87.6% vs. 80.9%), those who followed news related to COVID-19 on a daily basis (88.7% vs. 76.1%), and participants who had not acquired the infection (82.9%) compared to those who were infected with COVID-19 (72.3%). The aim of this study was to determine the impact of the pandemic on OCD screening and symptoms. New OCD symptoms were reported in a high proportion of the participants. The results of this study can provide guidance for psychiatrists and psychologists in the clinical approach and management of patients with OCD. Further focused research on the factors affecting the emergence or severity of OCD symptoms needs to be conducted in the future.
Background: Bariatric surgery is an effective long-term treatment for severe obesity. Psychological outcomes after surgery are clinically important. Methods: This prospective, non-interventional, longitudinal cohort enrolled adults scheduled for bariatric surgery at King Abdulaziz University Hospital (Jeddah, Saudi Arabia). The participants completed two online questionnaires: one pre-and one post-surgery (planned at approximately 6 months). Depression and anxiety symptoms were assessed using the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7). Positive screening was defined as PHQ-9 ≥10 and GAD-7 ≥10. Weight was self-reported using the questionnaires. Post-surgical complications were self-reported in the post-surgery questionnaire as ‘yes/no’ items. Pre- and post-surgery scores were compared using the paired t-test. Sensitivity analysis was assessed using the Wilcoxon signed-rank test. Proportions that screened positive were compared using the Z-test. Univariate linear regression was used to assess the association between symptom changes and demographic, clinical, and surgical factors. Analyses were conducted using Stata/AC v18. Results: Twenty-seven participants completed the pre-surgery questionnaire, and 23 completed the post-surgery questionnaire. The matched analyses included 23 participants. The mean (SD) age was 33.6 (10.4) years, and 11 (47.8%) were female. Although follow-up was planned at approximately 6 months, the completion time varied (mean 359.5 [273.5] days; median 224; range 84–906). The mean (SD) GAD-7 decreased from 6.0 (5.9) to 5.2 (5.5) (p=0.565), while the mean (SD) PHQ-9 decreased from 7.5 (7.3) to 5.9 (6.4) (p=0.430). The proportion screening positive decreased from 26.1% to 17.4% for GAD-7 (p=0.475), and from 26.1% to 13.0% for PHQ-9 (p=0.265). In the univariate models, post-surgical complications were associated with worse anxiety and depression trajectories, while prior anxiety diagnosis was associated with greater improvement in anxiety symptoms. Conclusion: In this cohort, the average depression and anxiety scores declined after bariatric surgery, although the overall changes were not statistically significant. Self-reported post-surgical complications were consistently associated with worse psychological outcomes. Our findings support the need for integrated psychiatric follow-ups during the bariatric surgical evaluations, before surgery and after surgery, particularly in patients with reported complications.